BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vigne J, Thackeray J, Essers J, Makowski M, Varasteh Z, Curaj A, Karlas A, Canet-Soulas E, Mulder W, Kiessling F, Schäfers M, Botnar R, Wildgruber M, Hyafil F; Cardiovascular study group of the European Society of Molecular Imaging. Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis. Mol Imaging Biol 2018;20:869-87. [PMID: 30250990 DOI: 10.1007/s11307-018-1264-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Dai Y, Sha X, Song X, Zhang X, Xing M, Liu S, Xu K, Li J. Targeted Therapy of Atherosclerosis Vulnerable Plaque by ROS-Scavenging Nanoparticles and MR/Fluorescence Dual-Modality Imaging Tracing. IJN 2022;Volume 17:5413-5429. [DOI: 10.2147/ijn.s371873] [Reference Citation Analysis]
2 Stadelmann VA, Boyd G, Guillot M, Bienvenu JG, Glaus C, Varela A. Automatic Quantification of Atherosclerosis in Contrast-Enhanced MicroCT Scans of Mouse Aortas Ex Vivo. Int J Biomed Imaging 2021;2021:4998786. [PMID: 34594369 DOI: 10.1155/2021/4998786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sangha GS, Goergen CJ, Prior SJ, Ranadive SM, Clyne AM. Preclinical techniques to investigate exercise training in vascular pathophysiology. Am J Physiol Heart Circ Physiol 2021;320:H1566-600. [PMID: 33385323 DOI: 10.1152/ajpheart.00719.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Canet Soulas E, Yazdani SK. Advanced atherosclerotic plaques in animal models versus human lesions: Key elements to translation. Biomechanics of Coronary Atherosclerotic Plaque 2021. [DOI: 10.1016/b978-0-12-817195-0.00003-2] [Reference Citation Analysis]
5 Stölting M, Geyer C, Helfen A, Hahnenkamp A, Usai MV, Wardelmann E, Kuhlmann MT, Wildgruber M, Höltke C. Monitoring Endothelin-A Receptor Expression during the Progression of Atherosclerosis. Biomedicines 2020;8:E538. [PMID: 33255872 DOI: 10.3390/biomedicines8120538] [Reference Citation Analysis]
6 De Dominicis C, Perrotta P, Dall'Angelo S, Wyffels L, Staelens S, De Meyer GRY, Zanda M. [18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging. ACS Med Chem Lett 2020;11:933-9. [PMID: 32435408 DOI: 10.1021/acsmedchemlett.9b00677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Vigne J, Hyafil F. Inflammation imaging to define vulnerable plaque or vulnerable patient. Q J Nucl Med Mol Imaging 2020;64. [DOI: 10.23736/s1824-4785.20.03231-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Giannakou S, Angelidis G, Tsougos I, Valotassiou V, Kappas K, Georgoulias P. Pet tracers for vulnerable plaque imaging. Ann Nucl Med 2020;34:305-13. [PMID: 32193790 DOI: 10.1007/s12149-020-01458-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Lairez O, Hyafil F. A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques? Semin Nucl Med 2020;50:311-8. [PMID: 32540028 DOI: 10.1053/j.semnuclmed.2020.02.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Vigne J, Cabella C, Dézsi L, Rustique E, Couffin AC, Aid R, Anizan N, Chauvierre C, Letourneur D, Le Guludec D, Rouzet F, Hyafil F, Mészáros T, Fülöp T, Szebeni J, Cordaro A, Oliva P, Mourier V, Texier I. Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE-/- mice. Nanomedicine 2020;25:102157. [PMID: 31982616 DOI: 10.1016/j.nano.2020.102157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Rucher G, Cameliere L, Fendri J, Anfray A, Abbas A, Kamel S, Dupas Q, Delcroix N, Berger L, Manrique A; STOP-AS investigators. Molecular imaging of endothelial activation and mineralization in a mouse model of accelerated atherosclerosis. EJNMMI Res 2019;9:80. [PMID: 31440854 DOI: 10.1186/s13550-019-0550-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Hyafil F, Vigne J. Nuclear Imaging: Focus on Vascular Probes. ATVB 2019;39:1369-78. [DOI: 10.1161/atvbaha.119.312586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Woodside DG. Nanoparticle Imaging of Vascular Inflammation and Remodeling in Atherosclerotic Disease. Curr Cardiovasc Imaging Rep 2019;12. [DOI: 10.1007/s12410-019-9501-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jenkins A, Januszewski A, O'Neal D. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovasc Endocrinol Metab 2019;8:14-27. [PMID: 31646294 DOI: 10.1097/XCE.0000000000000169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]